Since January 1st 2009, a mixed research unit, UPMC- INSERM-CNRS-AIM has been created which is headed by Thomas Voit, Scientific and Medical Director of the Institute. The primary objective of this new unit is to develop innovative approaches to cell, gene or pharmacological therapies, based on understanding the molecular pathophysiology of a disease, and therefore adapted to it.
UMRS 974 is comprised of 4 teams :
- Team 1 : Gisèle Bonne
Genetics and Pathophysiology of Neuromuscular Disorders - Team 2 : Gillian Butler-Browne
Remodeling, Regeneration and Cell Therapy of Striated Muscle - Team 3 : Luis Garcia
Biotherapies for Neuromuscular Diseases - Team 4 : Yves Fromes
Experimental physiology platform and in vivo evaluation of biotherapies
Contact: + 33 1 42 16 57 35
Update: November 2009
